Agios Pharmaceuticals | AGIO - Pre Tax Profit


Agios Pharmaceuticals reported $-99.11M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
Agios Pharmaceuticals USD -99.11M 9.94M Mar/2026
Alnylam Pharmaceuticals USD 177.81M 43.85M Jun/2026
Amgen USD 2.08B 570M Mar/2026
Arrowhead Research USD -178.9M 41.34M Jun/2026
Astellas Pharma JPY 186.51B 138.49B Jun/2026
AstraZeneca USD 4.81B 894M Jun/2026
Bayer EUR 321M 2.67B Jun/2026
Biogen USD 647.3M 269.6M Jun/2026
BioMarin Pharmaceutical USD 141.2M 168.36M Mar/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Daiichi Sankyo JPY -6.52B 113.25B Mar/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
Exelixis USD 262.68M 5.01M Jun/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Incyte USD 751.51M 407.91M Jun/2026
Ionis Pharmaceuticals USD -114M 21M Jun/2026
Merck USD -3.53B 6.95B Mar/2026
Moderna USD -1.33B 535M Mar/2026
Nektar Therapeutics USD -43.09M 8.39M Mar/2026
Novartis USD 4.27B 430M Jun/2026
Novartis USD 3.84B 1.33B Mar/2026
Pfizer USD -653M 5.84B Jun/2026
Puma Biotechnology USD 20.61M 24.76M Sep/2024
Regeneron Pharmaceuticals USD 1.53B 696.6M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sarepta Therapeutics USD -1.75M 344.92M Jun/2026
Vertex Pharmaceuticals USD 1.39B 138.9M Jun/2026